Tilray Inc (TLRY)
Healthcare
Drug Manufacturers - Specialty & Generic
4.54 $
+8.1%
vs. previous close
Closing price · As of: 1. Aug 2026
Who owns Tilray Inc (TLRY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
8.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.6%
No ownership data is available for this stock yet.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 30. Jul 2026 | Simon Irwin D | President and CEO | Other | 62,353 | 4.20 | 261,883 |
| 30. Jul 2026 | Simon Irwin D | President and CEO | Other | 117,647 | 0.00 | – |
| 30. Jul 2026 | Merton Carl A | Chief Financial Officer | Other | 9,161 | 4.20 | 38,476 |
| 30. Jul 2026 | Merton Carl A | Chief Financial Officer | Other | 16,656 | 0.00 | – |
| 30. Jul 2026 | Gendel Mitchell | Global General Counsel | Other | 12,921 | 4.20 | 54,268 |
| 30. Jul 2026 | Gendel Mitchell | Global General Counsel | Other | 24,379 | 0.00 | – |
| 30. Jul 2026 | Faltischek Denise M | Chief Strategy Officer | Other | 13,844 | 4.20 | 58,145 |
| 30. Jul 2026 | Faltischek Denise M | Chief Strategy Officer | Other | 26,120 | 0.00 | – |
| 29. Jul 2026 | Simon Irwin D | President and CEO | Other | 227,078 | 3.99 | 906,041 |
| 29. Jul 2026 | Simon Irwin D | President and CEO | Other | 428,448 | 0.00 | – |
| 29. Jul 2026 | Merton Carl A | Chief Financial Officer | Other | 30,209 | 3.99 | 120,534 |
| 29. Jul 2026 | Merton Carl A | Chief Financial Officer | Other | 60,417 | 0.00 | – |
| 29. Jul 2026 | Gendel Mitchell | Global General Counsel | Other | 46,344 | 3.99 | 184,913 |
| 29. Jul 2026 | Gendel Mitchell | Global General Counsel | Other | 87,440 | 0.00 | – |
| 29. Jul 2026 | Faltischek Denise M | Chief Strategy Officer | Other | 49,654 | 3.99 | 198,119 |
| 29. Jul 2026 | Faltischek Denise M | Chief Strategy Officer | Other | 93,685 | 0.00 | – |
| 21. Apr 2026 | David G Hopkinson | Director | Sell | 33,556 | 6.94 | 232,879 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: August 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.